Clinical outcomes of surgery of mitral valve regurgitation and coronary artery bypass grafting
|
|
- Della Bailey
- 5 years ago
- Views:
Transcription
1 doi: /icvts Interactive CardioVascular and Thoracic Surgery 5 (2006) Institutional report - Cardiac general Clinical outcomes of surgery of mitral valve regurgitation and coronary artery bypass grafting Srikrishna Sirivella*, Isaac Gielchinsky Newark Beth Israel Medical Center, Department of Cardiovascular and Thoracic Surgery, Newark University of Medicine & Dentistry of New Jersey, Newark, NJ 07112, USA Received 12 January 2006; received in revised form 13 April 2006; accepted 18 April 2006 Abstract The impact of etiology of associated mitral valve regurgitation and a valve procedure on operative and long-term outcomes after coronary bypass grafting surgery is yet to be clearly defined. Results of combined coronary artery bypass grafting and valve procedures for mitral valve regurgitation were retrospectively analyzed in 468 patients. The regurgitation was of ischemic in 45%, degenerative in 55% and 78% valve repairs, 22% valve replacements were performed. Severe coronary artery disease, acute myocardial infarction, low ejection fraction, ischemic mitral regurgitation, advanced heart failure symptoms, failure to use internal mammary artery, valve replacement surgery, and emergency operations are predictors of operative mortality. The 5-year survivals for propensity-matched patients of ischemic and degenerative disease were similar (66%), but 67% vs. 83%, respectively, for unmatched patients. Low ejection fraction (-35%), advanced age ()67 years), valve replacement surgery, residual mitral regurgitation, and severe coronary artery disease were predictors of poor longterm survival. Left ventricular remodeling processes, optimal valve procedure without residual mitral regurgitation and left ventricular function are important determinants of long-term outcome than the etiology of valve regurgitation Published by European Association for Cardio-Thoracic Surgery. All rights reserved. Keywords: Coronary artery bypass grafts (CABG); Ischemic mitral regurgitation; Mitral valve repair; Mitral valve replacement; Outcomes 1. Introduction The coexistence of mitral valve regurgitation (MR) in patients undergoing myocardial revascularization procedures is often associated with poor operative and long-term outcomes w1,2x. The influence of etiology of valve regurgitation and additional valve procedure on outcomes after coronary bypass surgery (CABG) is not yet clearly defined. We conducted this study in a group of patients with ischemic and degenerative disease, who underwent coronary artery bypass grafting surgery (CABG) and valve operations for MR to identify the predictors of operative mortality and long-term outcomes. We studied the effect of etiology of MR and type of a valve procedure on early and long-term survivals, functional outcomes and recurrence in valve regurgitation. 2. Patients and methods At Newark Beth Israel Medical Center, from July 1985 through June 2002, a total of 1687 mitral valve procedures were performed. This study consisted of 468 patients with MR who underwent a valve procedures and simultaneous *Corresponding author: 28 Cathedral Gardens Road, BRS Hospitals, Nungambakkam, Madras , India. Tel.: q ; fax: q address: s_sirivella475@yahoo.com (S. Sirivella). CABG. MR was due to degenerative disease in 55% (253) and ischemic in 45% (215) of patients. We have excluded patients having combined major cardiac operations, mitral valve procedures for infracted and ruptured papillary muscle subsequent to an acute myocardial infarction, calcific mitral valve disease (rheumatic origin) and regurgitation associated with extensive leaflet calcification andyor calcified annulus. The study was divided into two time periods (i.e. July 1985 through June 1992, and July 1992 through June 2002), and the outcomes were analyzed. After hospital discharge, the patients follow up had ranged from 3 months to 246 months. Median follow-up was 9.2 years and 20% of patients were followed up for 16 years or more Patient demographics and characteristics These were classified based on etiology of MR (i.e. ischemic or degenerative disease) and operative technique utilized in correction of regurgitation (i.e. valve repair versus prosthetic valve replacement) (Table 1). Equal percentage (22%) of both ischemic and degenerative diseases had valve replacements. The ischemic MR and valve replacement groups had increased incidence of diabetes, threevessel coronary disease, acute myocardial infarction, emergency operations, low probability of use of internal mammary graft, and longer cardiopulmonary bypass time as compared to degenerative and valve repair groups.
2 S. Sirivella, I. Gielchinsky / Interactive CardioVascular and Thoracic Surgery 5 (2006) Table 1 Patient / characteristics Patient variable Degenerative Ischemic P-value Valve P-valueq (ns253) (ns215) Replacement Repair ns103 ns365 Age )67 years 75% 55% % 66% 0.8 Sex ratio MyF NYHA Class IIIyIV 65% 85% % 76% CCS Class III & IV 32% 65% % 44% 0.34 Hypertension 70% 76% % 72% 0.15 Diabetes mellitus 12% 24% % 17% 0.03 Renal dysfunction* 7% 13% % 13% Acute MI 2% 24% % 12% Ejection fraction -35% 10% 43% % 28% vessel CAD 36% 82% % 54% Emergency operatons 3% 16% % 4% Valve replacement 22% 22% 0.99 Cross-clamp time 74"32 min 76"29 min "27 min 78"32 min CPB time 114"46 min 122"43 min q47 min 115"43 min 0.01 Number of grafts 2.26" " "1 2.3"1 0.9 LIMA 78% 52% % 76% Ischemic mitral 46% 46% 0.54 CCS s Canadian Cardiovascular Society; CPB s cardiopulmonary bypass; EF s ejection fraction; LIMA s left internal mammary artery; NYHA s New York Heart Association; MI s myocardial infarction; *serum creatinine )2.5 mgydl or a need for a dialysis. P-value s ischemic versus degenerative disease, P-valueq svalve replacement versus valve repair Operative technique The etiology of MR was determined by the patient s clinical history, echocardiographic findings and surgeon s observation at operating table. The diagnosis of MR was established after agreement of findings by two expert echocardiographers. Histological examination of resected leaflet tissue confirmed the diagnosis Ischemic mitral valve disease All patients had one or more prior myocardial infarctions (mostly inferior) with associated regional wall motion abnormalities w3x. The regurgitant jet is central with normal valve leaflets, chordae and papillary muscles. The leaflets failed to coapt or showed restricted mobility of valve leaflets (Carpentier type IIIb). Seventy-eight percent valve repairs and 22% valve replacements were done. Repair techniques were annuloplasty alone in 88% (posterior ring 72%, commissural 22%, and full ring 6%) and combination of annuloplasty with leaflet and chordal procedures in 12% due to mixed disease. In none of the patients undersized mitral rings were used. Repair was complex if leaflet procedures were combined with annuloplasty. Valve replacement was done for annular enlargement either without or with papillary muscle dysfunction (40%) Degenerative mitral valve disease The regurgitant jet was non-central or peripheral and the leaflets were floppy and thickened, with elongated or ruptured chordae-tendinae. In some patients with annular dilatation but without discernable leaflet prolapse, thick billowing of valve leaflets was noted. Valve repairs were done in 78% (197) of cases. Repairs were leaflet plication or quadrangular resection of posterior leaflet supple- Table 2 Post-operative complications Outcomes Degenerative Ischemic P-value Valve P-valueq (ns253) (ns215) Repair Replacement (ns365) (ns103) Inotropes )2 days 14% 43% % 39% IABP 2% 26% % 22% 0.05 Ventilator )24 h 13% 28% % 26% Atrial arrhythmias 47% 34% % 24% Ventricular tachycardia 7% 5% % 13% 0.01 Pneumonia 5% 14% % 14% Reoperationybleeding 4% 5% % 6% Sternal infection 1% 2% % 2% Renal failure 1% 2% % 4% Stroke 0% 3% % 2% Length of stayydays 9* (6 15) 10* (6 19) * (6 16) 11* (6 20) 0.5 ICU stayydays 2* (1 4) 4*(2 6) * (2 7) 3* (2 7) 0.4 Operative mortality 3.6% 14% % 14.5% IABP s intraaortic balloon pump; ICU s intensive care unit. P-value s ischemic versus degenerative disease, P-valueq svalve replacement versus valve repair. *() Median with range.
3 394 S. Sirivella, I. Gielchinsky / Interactive CardioVascular and Thoracic Surgery 5 (2006) Table 3 Risk predictors of operative mortality (univariate analysis) Variable Mortality (%) OR P-value Age )67 years Age -67 years 6.6 Femaley Male 6.8 Unstable angina No unstable angina 6 Diabetes mellitus No diabetes 8.5 Renal failure No renal failure 6 Acute MI No acute MI 6 Three-vessel CAD Two or 1-vessel CAD 2 EF -35% EF )35% 6 RV dysfunction Mildyno RV dysfunction 2 NYHA IIIyIV NYHA IyII 0.8 LIMA No LIMA 15 Emergencyyvs Elective 7 Crossclamp time ()90 min) (-90 min) 7 Ischemic disease Degenerative 3.6 Valve replacementy Valve repair 6.5 Simple repairy Complex repair 11 Operations patient survival was estimated by the Kaplan Meier technique, with log-rank tests to compare stratified groups. The important influencing variables or risks were analyzed by univariate and multivariate Cox proportional hazard models and expressed as risk ratios with 95% confidence intervals. Propensity scoring was done to match patients with degenerative and ischemic regurgitation to assess the long-term survival. Seventy variables were used in a logistic regression model (saturated) for analysis by the propensity score, which matched 117 patients of each group Operative mortality and morbidity Death occurred in 39 patients (within 30 days of operation or during the same hospitalization) with a mortality rate of 8.3%. Mortality during the years 1985 to 1992 was 12% compared to 5% during the years 1992 to The earlier period was characterized by more emergency operations (13 vs. 5.5%), less valve repairs (71 vs. 84%), and less frequent use of IMA graft (49 vs. 80%). The operation rate early after myocardial infarction was similar in both periods (12 vs. 12.5%). CAD s coronary artery disease; EF s ejection fraction; LIMA s left internal mammary artery; MI s myocardial infarction; NYHA s New York Heart Association. ORsodds ratio. mented by an annuloplasty (60%), leaflet transposition (11%), commissural leaflet resection 6%, bileaflets repairs (31%), chordal procedures (13%) and annuloplasty alone (9%). The repair was simple (in 136 patients), if it involves annuloplasty with or without leaflet resection or plication, and complex for chordal, anterior leaflet, and bileaflet repairs (61 patients). Valve replacements were done in 22% (56) of cases, mostly for bileaflet prolapse (67%), and chordal rupture (55%). Overall valve repair was performed in 78% (365) and prosthetic mitral valve replacement in 22% (103) of cases. Attempts were made to preserve the posterior (58%), anterior (6%) and both leaflets (2%) during valve replacements w4x. Associated preoperative tricuspid regurgitation of 2q or more was repaired Statistical analysis All statistical analysis was performed using SAS software (SAS Institute, Cary, North Carolina). Univariate analyses included two-tailed Wilcoxon rank sum or t-tests for continuous variables and x or Fisher s exact tests for discrete 2 variables. A P-value )0.05 was considered not statistically significant. NYHA functional class IIIyIV symptoms and Fig. 1. A. Overall survival (Kaplan Meier) of patients undergoing mitral valve repair or replacement plus coronary bypass graft (CABG). B. Overall CHF free survival of patients undergoing mitral valve repair or replacement and CABG.
4 S. Sirivella, I. Gielchinsky / Interactive CardioVascular and Thoracic Surgery 5 (2006) The operative mortality for ischemic disease was 14% as compared to 3.6% for degenerative disease. The mortality for prosthetic valve replacement was higher as compared to valve repair (14.5 vs. 6.5%, PF0.05). The major operative morbidity rates were higher in the ischemic group and valve replacement was associated with more complications than valve repair (Table 2). The risk predictors of operative mortality by univariate analysis are shown in Table Long-term results The overall survival at 5 and 10 years was 73% (95% confidence interval (CI): 65% to 76%) and 52% (95% CI: 42% to 56%), respectively (Fig. 1A), but CHF-free survival rates were 63% (95% CI: 54% to 66%) at 5 years, 39% (95% CI: 26% to 42%) at 10 years (Fig. 1B). The 5- and 10-year survivals for early ( ) vs. recent study ( ) were 67% and 44% vs. 72% and 48% (Ps0.06) respectively. The patients )67 years had poor survivals as compared to age -67 years (62% vs. 78% at 5 years, 54% vs. 37% at 10 years, PF0.0001). Operations in the presence of acute MI had no influence on long-term survival (60%, 42% vs. 69%, 45% (no MI) at 5 and 10 years, respectively, Ps0.09). Poor survivals were associated with preoperative NYHA class III & IV symptoms, diminished left ventricular function (EF -0.35), three-vessel coronary artery disease, right ventricular dysfunction, and a valve replacement surgery (Fig. 2). Survivals were poor for ischemic MR as compared to degenerative MR (i.e. 67% {95% CI 62% to 74%} vs. 83% {95% CI 71% to 86%} at 5 years, 47% {95% CI 43% to 55%} vs. 62% {95% CI 54% to 72%} at 10 years (Fig. 3A), but were similar for propensity-matched patients (117 each) of both groups (65% vs. 66% at 5 years and 46% vs. 48% at 10 years, Ps0.23 (Fig. 3B). The risk predictors for survival on univariate and multivariate analyses are shown in Table 4. The important independent predictors of poor long-term survival were residual mitral valve regurgitation (grade II or more) at hospital discharge, three-vessel coronary artery disease, reduced ventricular function, valve replacement surgery, but not the etiology of valve regurgitation Recurrent CHF The cumulative risk of developing CHF was 22% (95% CI: 18% to 32%) at 5 years, 46% (95% CI: 38% to 58%) at 10 years. Residual MR? grade II was associated with Fig. 2. Overall survival (Kaplan Meier) of patients shown in percentages on Y-axis, patients at risk were shown on X-axis at indicated time periods. A. Survival stratified by preoperative NYHA functional class (I & II and III & IV). B. Survival stratified by preoperative left ventricular ejection fraction (EF). C. Survival stratified by extent of coronary artery disease. D. Survival stratified by valve repair versus valve replacement. E. Survival stratified by preoperative right ventricular function. Fig. 3. A. Unmatched overall survival of patients with degenerative and Ischemic mitral regurgitation (MR) and CABG. B. Overall survival of propensity matched patients (117 each) with degenerative and ischemic disease.
5 396 S. Sirivella, I. Gielchinsky / Interactive CardioVascular and Thoracic Surgery 5 (2006) Table 4 Predictors for long-term survival (univariate and multivariate analyses) Risk variable Univariate Multivariate Multivariate P-value Risk ratio (CI) P-value Age )67 yearsy ( ) Age -67 years EF -35%y ( ) EF )35% Acute MI 0.09 No acute MI Three-vessel CAD ( ) Oney2-vessel CAD MR? grade II ( ) No MR NYHA IIIyIV ( ) NYHA IyII RV dysfunction ( ) 0.09 No RV dysfunction Ischemic ( ) 0.21 Degenerative LIMA ( ) 0.46 No LIMA left ventricular remodeling, which occurs after myocardial infarction, may continue several months and may impact long-term outcomes in both types of regurgitation w6,8x. Residual MR after a valve procedure influences the recurrent CHF, functional outcomes and long-term survival in both degenerative and ischemic MR. The volume burden imposed by residual MR (grade II or more) impairs ventricular remodeling processes and progresses to recurrent congestive heart failure w9,10x. MR detected in the postoperative period is managed by optimizing the preload and after-load with beta blockers, angiotensin converting enzyme inhibitors and inotropes, if a faulty valve repair technique was ruled out w6,11x. Insertion of a prosthetic valve is mandatory if doubt exists about the adequacy of mitral valve repair. Poor long-term results observed in this study for residual MR dictates a rationale for a valve repair if the regurgitation jet is of moderate in patients undergoing concomitant CABG. Several important studies have demonstrated that MR which persists long-term in patients with significant coronary artery disease results in poor survival w11,12x. Despite controversy on the choice of an optimal corrective technique for ischemic MR, mitral valve repair in good-risk Replacementy ( ) Repair Operations CAD s coronary artery disease; CI s confidence interval; EF s ejection fraction; LIMA s left internal mammary artery; MR s mitral regurgitation; NYHA s New York Heart Association. increased incidence of CHF (Fig. 4A) and decreased survivals (Fig. 4B). The independent risk predictors for CHF on long follow-up were residual MR? grade II at hospital discharge, ejection fraction -35% (Ps0.002), preoperative NYHA class IIIyIV symptoms (Ps0.014), and significant right ventricular dysfunction (Ps0.02) Freedom from re-operation Freedom from operation at 5 and 10 years was 95% (95% CI: 87% to 98%), and 87% (95% CI: 72% to 94%) after valve repair and 89% (95% CI: 75 99%) and 78% (95% CI: 57% to 100%) after a valve replacement. The overall failure rates for simple vs. complex valve repairs were similar (5 vs. 6%), but complex valve repair in ischemic MR had resulted in a failure in 60% (12 of 20 patients), and 25% (5 patients) required valve placement. 3. Discussion The determinants of operative risk and poor long-term survival noted in this study for surgery of MR and associated CABG is consistent with several others w3,5,6x. Ischemic etiology of mitral valve regurgitation, however, was not found to be an independent predictor of long-term survival. The equally poor long-term outcomes associated for matched patients of both degenerative and ischemic disease may imply that in the presence of ongoing ischemia Fig. 4. A. The incidence of postoperative CHF. Patients were stratified by the presence or absence of residual MR? Grade II at hospital discharge. B. Overall survival of patients stratified by the presence or absence of residual MR? Grade II at discharge. CHFscongestive heart failure; NYHAsNew York Heart Association.
6 S. Sirivella, I. Gielchinsky / Interactive CardioVascular and Thoracic Surgery 5 (2006) patients was associated with lower operative mortality and better survival than with prosthetic valve replacement, though this advantage in survival was not seen in poor-risk patients w1,13x. The extent of left and right ventricular dysfunction, severity of the coronary artery disease and optimal corrective technique in ischemic MR are paramount. Due to increased failure of complex valve repairs in ischemic MR, a prosthetic valve replacement may be warranted at an initial operation, but under-sizing of mitral annuloplasty ring may improve results of valve repair. References w1x Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J, Lytle BW, McCarthy PM. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac CardioVasc Surg 2001;122: w2x Wong DR, Agnihotri AK, Hung JW, Vlahakes GJ, Akins CW, Hilgenberg AD, Madsen JC, MacGillivray TE, Picard MH, Torchiana DF. Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation. Ann Thorac Surg 2005;80: w3x Akins CW, Hilgenberg AD, Buckley MJ, Vlahakes GJ, Torchiana DF, Daggett WM, Austen WG. Mitral valve replacement versus reconstruction for degenerative or ischemic mitral regurgitation. Ann Thorac Surg 1994;58: w4x DeAnda Jr A, Komeda M, Nikolic SD, Daughters GT, Ingels NB, Miller DC. Left ventricular function, twist, and tecoil after mitral valve replacement. Circulation 1995;92: w5x Harris KM, Sundt TM, Aeppli D, Sharma R, Barzilai B. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 2002;74: w6x Duarte IG, Shen Y, MacDonald MJ, Jones EL, Craver JM, Guyton RA. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: late results. Ann Thorac Surg 1999;68: w7x St John-Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction; pathophysiology and therapy. Circulation 2000;101: w8x Levine RA, Schumenthal E. Ischemic regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation Aug 2005; 112: w9x Ling LH, Enriquez-Sarano M, Seward JB, Orszulak TA, Schaff HV, Bailey KR, Tajik AJ, Frye RL. Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. Circulation 1997;96: w10x Kuwaki K, Kiyofumi M, Tsukamoto M, Abe T. Early and late results of mitral valve repair for mitral valve regurgitation. J Cardiovasc Surg 2000;41: w11x Aklog L, Filsoufi F, Flores KQ, Chen RH, Cohn LH, Nathan NS, Byrne JG, Adams DH. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104: w12x Lamas GA, Mitchell GF, Flaker GC, Smith Jr SC, Gersh BJ, Basta L, Moyé L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after myocardial infarction. Circulation 1997;96: w13x Grossi EA, Goldberg JD, LaPietra A, Ye X, Zakow P, Sussman M, Delianides J, Culliford AT, Esposito RA, Ribakove GH, Galloway AC, Colvin SB. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac CardioVasc Surg 2001;122:
Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationSurgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse
Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois
More informationQuality Outcomes Mitral Valve Repair
Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding
More informationThe use of mitral valve (MV) repair to correct mitral
Outcomes and Long-Term Survival for Patients Undergoing Repair Versus Effect of Age and Concomitant Coronary Artery Bypass Grafting Vinod H. Thourani, MD; William S. Weintraub, MD; Robert A. Guyton, MD;
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More informationIschemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival?
Ischemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival? A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Jeevanantham Rajeswaran, MS, Maurice Mawad, MD, Patrick M. McCarthy, MD,
More informationDegenerative mitral valve disease is the leading cause of
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease Willem Flameng, MD, PhD; Paul Herijgers, MD, PhD; Kris Bogaerts, MSc Background Durability assessment of
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationIschemic mitral regurgitation (IMR) is an insufficiency of
Repair Techniques for Ischemic Mitral Regurgitation Damien J. LaPar, MD, MSc, and Irving L. Kron, MD Ischemic mitral regurgitation (IMR) is an insufficiency of the mitral valve (MV) secondary to myocardial
More informationJournal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1
More informationValve Analysis and Pathoanatomy: THE MITRAL VALVE
: THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery
More informationIschaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic
Correspondence to: Professor Bernard Iung, Service de Cardiologie, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France; bernard.iung@ bch.ap-hop-paris.fr Valve
More informationMitral valve (MV) repair is preferred over replacement. Is Mitral Valve Repair Superior to Replacement in Elderly Patients?
Is Mitral Valve Superior to in Elderly Patients? Gorav Ailawadi, MD, Brian R. Swenson, MD, MS, Micah E. Girotti, BS, Leo M. Gazoni, MD, Benjamin B. Peeler, MD, John A. Kern, MD, Lynn M. Fedoruk, MD, and
More informationLong term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation
Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications
More informationRecurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?
Surgery for Acquired Cardiovascular Disease Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD, Joseph A. Dearani, MD,
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationTHE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia
THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN Carpentier s principles
More informationIschemic mitral regurgitation (IMR) is a mechanical complication of myocardial
Clinical Investigation Hayrettin Tekumit, MD Ali Riza Cenal, MD Kemal Uzun, MD Cenk Tataroglu, MD Esat Akinci, MD Ring Annuloplasty in Chronic Ischemic Mitral Regurgitation Encouraging Early and Midterm
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationAnn Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article
Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical
More informationIsolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function
Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Ashish S. Shah, MD, Steven A. Hannish, MD, Carmelo A. Milano, MD, and Donald D. Glower, MD Department of General and Thoracic
More informationSurgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi
Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall
More informationSurgical repair techniques for IMR: future percutaneous options?
Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationAlthough most surgeons would agree that severe mitral
Does Coronary Artery Bypass Grafting Alone Correct Moderate Ischemic Mitral Regurgitation? Lishan Aklog, MD; Farzan Filsoufi, MD; Kathryn Q. Flores, MD; Raymond H. Chen, MD; Lawrence H. Cohn, MD; Nadia
More informationThe New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography
Clinical Practice This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines,
More informationLate outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting
Surgery for Acquired Cardiovascular Disease Late outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting Hari R. Mallidi, MD
More informationInfluence of Atrial Fibrillation on Outcome Following Mitral Valve Repair
Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationLong-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection
Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection Yoshimasa Sakamoto, MD, Kazuhiro Hashimoto, MD, Hiroshi Okuyama, MD, Shinichi Ishii,
More informationMitral valve repair in ischemic mitral regurgitation
doi:10.1510/mmcts.2004.000521 Mitral valve repair in ischemic mitral regurgitation Antonio Maria Calafiore a, *, Michele Di Mauro b, Marco Contini b, Luca Weltert a, Antonio Bivona b a Division of Cardiac
More informationMitral valve surgery has changed considerably in the past decades and is now indicated
Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation
More informationMitral Valve Repair for 52 Patients with Severe Left Ventricular Dysfunction
Original Article Mitral Valve Repair for 52 Patients with Severe Left Ventricular Dysfunction Mikiko Murakami, MD, Hiroki Yamaguchi, MD, PhD, Yuji Suda, MD, PhD, Tomohiro Asai, MD, PhD, Michiaki Sueishi,
More informationIs a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?
Interactive CardioVascular and Thoracic Surgery Advance Access published May 7, 2012 Interactive CardioVascular and Thoracic Surgery 0 (2012) 1 5 doi:10.1093/icvts/ivr141 BEST EVIDENCE TOPIC Is a minimally
More informationPercutaneous Mitral Valve Repair
Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral
More informationDisclosure Statement of Financial Interest Saibal Kar, MD, FACC
MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
More informationThe risk-benefit ratio of mitral valve operation is
Degenerative Mitral Regurgitation: When Should We Operate? Malcolm J. R. Dalrymple-Hay, PhD, Mark Bryant, Richard A. Jones, MRCP, Stephen M. Langley, FRCS, Steven A. Livesey, FRCS, and James L. Monro,
More informationORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
Nagoya J. Med. Sci. 78. 369 ~ 376, 2016 doi:10.18999/nagjms.78.4.369 ORIGINAL PAPER The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan
More informationPosterior leaflet prolapse is the most common lesion seen
Techniques for Repairing Posterior Leaflet Prolapse of the Mitral Valve Robin Varghese, MD, MS, and David H. Adams, MD Posterior leaflet prolapse is the most common lesion seen in degenerative mitral valve
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationDegenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention
Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral
More informationIschemic Mitral Valve Disease: Repair, Replace or Ignore?
Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationMitral Valve Repair at King Chulalongkorn Memorial Hospital; A Preliminary Report.
Mitral Valve Repair at King Chulalongkorn Memorial Hospital; A Preliminary Report. Jiranut Cholteesupachai, MD.*, Smonporn Boonyaratavej Songmuang, MD.*, Seri Singhatanadgige, MD. ** King Chulalongkorn
More informationClinical material and methods. Copyright by ICR Publishers 2007
16847_JHVD_Biancari_3197_(116-121)_r1:Layout 1 21/3/07 17:07 Page 116 Predicting Immediate and Late Outcome after Surgery for Mitral Valve Regurgitation with EuroSCORE Jouni Heikkinen, Fausto Biancari,
More informationMitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System
Case Report Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Antonio Chiricolo 1*, Leonard Y Lee 2 1 Department of Anesthesiology, Rutgers
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationMidterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients
Midterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients Kevin D. Accola, MD, Meredith L. Scott, MD, Paul A. Thompson, MD, George J. Palmer III, MD, Mark E. Sand,
More informationFactors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery
European Journal of Cardio-thoracic Surgery 28 (2005) 783 787 www.elsevier.com/locate/ejcts Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery Saida
More informationMitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease
Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease Kenji Kuwaki, MD, PhD, Nobuyoshi Kawaharada, MD, PhD, Kiyofumi Morishita, MD, PhD, Tetsuya Koyanagi,
More informationChanging profile of patients undergoing redo-coronary artery surgery q
European Journal of Cardio-thoracic Surgery 21 (2002) 205 211 www.elsevier.com/locate/ejcts Changing profile of patients undergoing redo-coronary artery surgery q Frans M. van Eck, Luc Noyez*, Freek W.A.
More informationPercutaneous Mitral Valve Repair
Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationRisk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects
Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the
More informationRestoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery
Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery John M. Stulak, MD,* Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thomas A. Orszulak,
More informationThree-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation
Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8
More informationComparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse
European Journal of Cardio-thoracic Surgery 36 (2009) 532 538 www.elsevier.com/locate/ejcts Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse
More informationMitral valve repair is the gold standard to treat mitral regurgitation.
Papillary muscle repositioning for repair of anterior leaflet prolapse caused by chordal elongation Gilles D. Dreyfus, MD, PhD, FRCS, Olivio Souza Neto, MD, and Stéphane Aubert, MD, MSc Objective: Anterior
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationTranscatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry
Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry A. Colli, E. Bizzotto, E. Manzan, L. Besola, F. Zucchetta, D.Pittarello,
More informationAortic valve repair: When and how to employ this novel approach?
Aortic valve repair: When and how to employ this novel approach? Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical
More informationI challenging management problems in cardiac surgery. Mitral Valve Repair for Ischemic Mitral Insufficiency
Mitral Valve Repair for Ischemic Mitral Insufficiency William G. Hendren, MD, James J. Nemec, MD, Bruce W. Lytle, MD, Floyd D. Loop, MD, Paul C. Taylor, MD, Robert W. Stewart, MD, and Delos M. Cosgrove
More informationDurability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement
Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationOverview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan
Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!
More informationSurgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital
Mitral Valve Surgical intervention Graham McCrystal Chairs: Rajesh Nair & Gerard Wilkins Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital
More informationOutcome of mitral valve repair in patients with preoperative atrial fibrillation
Outcome of mitral valve repair in patients with preoperative atrial fibrillation Should the maze procedure be combined with mitral valvuloplasty? To examine late outcome of mitral valve repair in patients
More informationThe benefits of mitral valve reconstruction for operative
Prophylactic Mitral Reconstruction for Mitral Regurgitation Iva A. Smolens, MD, Francis D. Pagani, MD, PhD, G. Michael Deeb, MD, Richard L. Prager, MD, Seema S. Sonnad, PhD, and Steven F. Bolling, MD Section
More informationIndex. B B-type natriuretic peptide (BNP), 76
Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationMITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)
UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,
More informationVALVE REPAIR VERSUS REPLACEMENT FOR MITRAL INSUFFICIENCY: WHEN IS A MECHANICAL VALVE STILL INDICATED?
VALVE REPAIR VERSUS REPLACEMENT FOR MITRAL INSUFFICIENCY: WHEN IS A MECHANICAL VALVE STILL INDICATED? Eugene A. Grossi, MD Aubrey C. Galloway, MD Jeffrey S. Miller, MD Greg H. Ribakove, MD Alfred T. Culliford,
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More informationMitraClip in the ICCU: Which Patient will Benefit?
MitraClip in the ICCU: Which Patient will Benefit? DAVID MEERKIN STRUCTURAL A ND CONGENITAL HEART DISEASE UNIT SHAARE ZEDEK MEDICAL CENTER JERUSALEM Conflict of Interest No relevant disclosures Complex
More informationMitral valve repair is the procedure of choice in SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE
SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE MITRAL VALVE REPAIR AND REPLACEMENT FOR RHEUMATIC DISEASE Terrence M. Yau, MD, MSc Yasser A. Farag El-Ghoneimi, MD Susan Armstrong, MSc Joan Ivanov, MSc Tirone
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationSteven F Bolling Professor of Cardiac Surgery University of Michigan
Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan Functional MR Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure,
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationIncidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery
Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery JUAN S. JARAMILLO, MD Cardiovascular Surgery Clinica CardioVID Medellin Colombia DISCLOSURE INFORMATION Consultant
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More informationPreoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty
Original Article Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty Keiichiro Kondo, MD, Yoshihide Sawada, MD, and Shinjiro Sasaki, MD, PhD It is necessary
More informationLes valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative?
Réunion d automne de la SSC à Lucerne le 24.11.2011 Incertitudes dans le travail cardiologique quotidien Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère
More informationTREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC
TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS
More informationMitral annuloplasty in patients with ischemic versus dilated cardiomyopathy q
European Journal of Cardio-thoracic Surgery 23 (2003) 567 572 www.elsevier.com/locate/ejcts Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy q Zoltan A. Szalay a, *, Ali Civelek
More informationPrimary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017
Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board
More informationMitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique
Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique Michele De Bonis, MD; Elisabetta Lapenna, MD; Giovanni La Canna, MD; Eleonora
More informationSince 1990, there has been a steady increase in cardiac
Outcomes of Patients Undergoing Concomitant Aortic and Mitral Valve Surgery in Northern New England Bruce J. Leavitt, MD; Yvon R. Baribeau, MD; Anthony W. DiScipio, MD; Cathy S. Ross, MS; Reed D. Quinn,
More information